Cita APA

Fazeli Farsani, S., Taniguchi, A., Ikeda, R., Brodovicz, K. G., & Bartels, D. B. (2019). Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post‐marketing surveillance study in Japan. J Diabetes Investig.

Chicago Style Citation

Fazeli Farsani, Soulmaz, Atsushi Taniguchi, Rie Ikeda, Kimberly G. Brodovicz, i Dorothee B. Bartels. "Preferential Prescribing of Linagliptin in Type 2 Diabetes Patients in an Expanded Post‐marketing Surveillance Study in Japan." J Diabetes Investig 2019.

Cita MLA

Fazeli Farsani, Soulmaz, et al. "Preferential Prescribing of Linagliptin in Type 2 Diabetes Patients in an Expanded Post‐marketing Surveillance Study in Japan." J Diabetes Investig 2019.